Literature DB >> 15197532

Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds.

Andras Bilkei-Gorzo1, Ildiko Racz, Kerstin Michel, Anne Zimmer, Dietrich Klingmüller, Andreas Zimmer.   

Abstract

RATIONALE: The phenotype of genetically modified animals is thought to result from an interaction of gene manipulation with the genetic background and environmental factors.
OBJECTIVES: To test the behavioral and drug responses of Penk1(-/-) mice on different genetic backgrounds.
METHODS: Congenic C57BL/6J and DBA/2J mouse strains with a targeted deletion of the Penk1 gene were generated. Behavior and drug effects were tested in models of pain and anxiety.
RESULTS: Penk1(-/-) mice showed exaggerated responses to painful or threatening environmental stimuli, but the expressivity of the mutant phenotype was strongly dependent on the behavioral paradigm and on the genetic background. For example, elevated levels of anxiety were readily detectable in C57BL/6J-Penk1(-/-) mice in the light-dark and startle response tests, but not in the social interaction test. In contrast, we found elevated levels of anxiety in DBA/2J-Penk1(-/-) mice only in the zero-maze and social interaction tests. In some cases, the idiosyncratic behavior masked the appearance of the knockout gene effect. The activity of the anxiogenic drug, m-chlorophenylpiperazine, but not the anxiolytic drug diazepam, was strain and genotype dependent. Mice with the Penk1 mutation on the DBA/2J, but not on other genetic backgrounds, showed an increased opioid-dependent stress-induced analgesia.
CONCLUSIONS: (1) The behavioral effects of the Penk1 gene deletion persists on different genetic backgrounds, but its detection sometimes requires the use of different behavioral paradigms. (2) The behavior of the background strain should be considered in the analysis of knockout mice to avoid floor and ceiling effects, which may mask the phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197532     DOI: 10.1007/s00213-004-1904-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

Review 1.  Use of genetic analyses to refine phenotypes related to alcohol tolerance and dependence.

Authors:  J C Crabbe
Journal:  Alcohol Clin Exp Res       Date:  2001-02       Impact factor: 3.455

2.  The difference in stress-induced analgesia in C57BL/6 and DBA/2 mice: a search for biochemical correlates.

Authors:  B Przewłocka; J Vetulani; W Lasoń; M Dziedzicka; J Silberring; C Castellano; R Przewłocki
Journal:  Pol J Pharmacol Pharm       Date:  1988 Sep-Oct

3.  Genetic background changes the pattern of forebrain commissure defects in transgenic mice underexpressing the beta-amyloid-precursor protein.

Authors:  F Magara; U Müller; Z W Li; H P Lipp; C Weissmann; M Stagljar; D P Wolfer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

4.  Overexpression of agouti protein and stress responsiveness in mice.

Authors:  R B Harris; J Zhou; M Shi; S Redmann; R L Mynatt; D H Ryan
Journal:  Physiol Behav       Date:  2001-07

5.  Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice.

Authors:  G Griebel; C Belzung; G Perrault; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  2000-02       Impact factor: 4.530

Review 6.  Exploring the opioid system by gene knockout.

Authors:  Brigitte L Kieffer; Claire Gavériaux-Ruff
Journal:  Prog Neurobiol       Date:  2002-04       Impact factor: 11.685

7.  Inbred strain differences in prepulse inhibition of the mouse startle response.

Authors:  R Paylor; J N Crawley
Journal:  Psychopharmacology (Berl)       Date:  1997-07       Impact factor: 4.530

Review 8.  Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies.

Authors:  J N Crawley; J K Belknap; A Collins; J C Crabbe; W Frankel; N Henderson; R J Hitzemann; S C Maxson; L L Miner; A J Silva; J M Wehner; A Wynshaw-Boris; R Paylor
Journal:  Psychopharmacology (Berl)       Date:  1997-07       Impact factor: 4.530

9.  Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background.

Authors:  A Holmes; Q Lit; D L Murphy; E Gold; J N Crawley
Journal:  Genes Brain Behav       Date:  2003-12       Impact factor: 3.449

10.  Comparisons between warm and cold water swim stress in mice.

Authors:  P O'Connor; R E Chipkin
Journal:  Life Sci       Date:  1984-08-06       Impact factor: 5.037

View more
  25 in total

1.  Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes.

Authors:  R J Rodgers; R Augar; N Berryman; C J Hansom; M L O'Mahony; R M Palmer; A Stevens; A J Tallett
Journal:  Psychopharmacology (Berl)       Date:  2006-06-27       Impact factor: 4.530

2.  Increased morphine analgesia and reduced side effects in mice lacking the tac1 gene.

Authors:  A Bilkei-Gorzo; J Berner; J Zimmermann; R Wickström; I Racz; A Zimmer
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 3.  Usefulness of knockout mice to clarify the role of the opioid system in chronic pain.

Authors:  Rafael Maldonado; Josep Eladi Baños; David Cabañero
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

4.  Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors.

Authors:  A Bilkei-Gorzo; I Racz; O Valverde; M Otto; K Michel; M Sastre; M Sarstre; A Zimmer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-12       Impact factor: 11.205

5.  Enkephalin downregulation in the nucleus accumbens underlies chronic stress-induced anhedonia.

Authors:  Jean-François Poulin; Sylvie Laforest; Guy Drolet
Journal:  Stress       Date:  2013-10-31       Impact factor: 3.493

6.  The opioid peptides enkephalin and beta-endorphin in alcohol dependence.

Authors:  Ildiko Racz; Britta Schürmann; Anna Karpushova; Martin Reuter; Sven Cichon; Christian Montag; Robert Fürst; Christian Schütz; Petra E Franke; Jana Strohmaier; Thomas F Wienker; Lars Terenius; Urban Osby; Agneta Gunnar; Wolfgang Maier; Andras Bilkei-Gorzó; Markus Nöthen; Andreas Zimmer
Journal:  Biol Psychiatry       Date:  2008-06-27       Impact factor: 13.382

7.  Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression.

Authors:  Sarah Ann R Anderson; Michael Michaelides; Parisa Zarnegar; Yanhua Ren; Pernilla Fagergren; Panayotis K Thanos; Gene-Jack Wang; Michael Bannon; John F Neumaier; Eva Keller; Nora D Volkow; Yasmin L Hurd
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

8.  Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine.

Authors:  Inge Sillaber; Markus Panhuysen; Markus S H Henniger; Frauke Ohl; Claudia Kühne; Benno Pütz; Thomas Pohl; Jan M Deussing; Marcelo Paez-Pereda; Florian Holsboer
Journal:  Psychopharmacology (Berl)       Date:  2008-07-16       Impact factor: 4.530

9.  Modulation of the Ca2+ conductance of nicotinic acetylcholine receptors by Lypd6.

Authors:  Martin Darvas; Marco Morsch; Ildiko Racz; Seifollah Ahmadi; Dieter Swandulla; Andreas Zimmer
Journal:  Eur Neuropsychopharmacol       Date:  2009-04-29       Impact factor: 4.600

10.  Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours.

Authors:  Florence Noble; Nadia Benturquia; Andras Bilkei-Gorzo; Andreas Zimmer; Bernard P Roques
Journal:  Psychopharmacology (Berl)       Date:  2007-10-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.